Amrutanjan Health Care Ltd.

•

amrutanjan.comBSE: 590006NSE: AMRUTANJAN

Market Cap₹ 1,418 Cr.

Current Price

High / Low₹ 774 / 483

Stock P/E26.3

Book Value₹ 130

Price to Book3.86

Dividend Yield1.00 %

ROCE22.5 %

ROE16.6 %

Face Value₹ 1

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2026 • OTC Products: 65.3% • Women Hygiene: 27.8% • Beverages: 6.3%

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Company is almost debt free
Company has a healthy return on capital (ROCE) of 22.2%
Working capital cycle has improved - days down from 166 to 120
Stock looks reasonably valued - P/E of 26.3 is below its historical median
Company has a consistent dividend-paying track record
Company generates healthy free cash flow

CONS

Promoter holding has decreased over last 2 years: -4.1pp
Company has delivered a poor profit growth of -1.1% over past five years

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	SUNPHARMA	1842.00	36.54	441957.50	0.87	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9326.00	84.64	247576.00	0.32	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4975.00	86.76	189233.01	0.76	566.00	3.28	4921.00	57.32	19.27	33.81
4.	ZYDUSLIFE	1119.50	24.74	111670.55	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
5.	CIPLA	1365.00	32.72	110272.68	0.95	785.55	-39.18	7119.28	4.13	16.00	16.73
6.	LAURUSLABS	1970.35	97.37	106460.42	0.10	362.07	123.94	2026.31	29.10	18.20	31.50
7.	DRREDDY	1161.00	30.07	96906.38	0.69	435.60	-69.10	8099.80	-5.21	13.75	10.63
8.	AUROPHARMA	1675.45	25.97	96401.69	0.24	1032.03	25.22	9150.35	17.44	12.76	20.54
9.	LUPIN	2096.00	17.34	95842.92	0.86	1416.98	16.01	8276.89	34.28	28.86	29.59
10.	MANKIND	2277.00	46.04	94050.37	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
11.	GLENMARK	2416.90	37.94	68210.88	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	AMRUTANJAN	490.35	67.05	1417.63	1.00	4.37	-47.46	102.97	9.48	22.46	6.06

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	78	99	117	127	84	110	123	135	94	118	141	150	103
	71	92	95	111	80	96	99	118	86	101	116	124	99
Operating Profit	7	7	22	16	4	14	23	18	8	17	25	26	4
OPM %	9.18%	6.89%	18.44%	12.77%	4.24%	12.38%	19.02%	13.07%	8.98%	14.04%	17.85%	17.05%	4.16%
	4	4	4	5	4	4	4	5	4	4	3	-3	6
Interest	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	1	2	2	2	2	2	2	2	2	2	2	2	2
Profit before Tax	9	9	24	20	6	16	26	21	11	19	26	21	6
Tax %	25.66%	25.62%	26.40%	30.34%	27.24%	26.04%	25.93%	27.23%	26.40%	27.33%	26.21%	22.93%	28.08%
Net Profit	7	7	17	14	5	12	19	15	8	14	19	16	4
	2.40	2.36	6.05	4.72	1.60	4.08	6.66	5.25	2.87	4.83	6.73	5.60	1.51

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	212	220	253	261	333	406	380	421	452	503	511
	182	192	222	231	266	328	335	369	394	427	440
Operating Profit	30	28	31	31	67	78	45	52	58	76	72
OPM %	14.06%	12.86%	12.21%	11.79%	20.20%	19.11%	11.73%	12.32%	12.91%	15.09%	13.98%
	7	8	7	8	19	17	15	16	18	9	10
Interest	1	0	0	0	1	1	0	0	0	0	0
Depreciation	3	3	3	4	4	4	5	6	7	6	7
Profit before Tax	34	33	35	34	82	91	54	62	69	78	73
Tax %	35.19%	39.16%	29.32%	27.20%	25.29%	25.82%	25.74%	27.40%	26.47%	25.64%	25.71%
Net Profit	22	20	25	25	61	67	40	45	51	58	54
EPS	0.00	13.67	0.00	8.58	20.93	22.98	13.63	15.56	17.58	20.03	—
Dividend Payout %	25.81%	28.43%	25.64%	24.47%	20.06%	20.01%	33.76%	29.57%	26.16%	24.46%	—

COMPOUNDED SALES GROWTH

10 Years:: 11%
5 Years:: 9%
3 Years:: 10%

COMPOUNDED PROFIT GROWTH

10 Years:: 10%
5 Years:: -1%
3 Years:: 13%

STOCK PRICE CAGR

10 Years:: 9%
5 Years:: -7%
3 Years:: -8%
1 Year:: -35%

RETURN ON EQUITY

10 Years:: 19%
5 Years:: 18%
3 Years:: 16%
Last Year:: 17%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	3	3	3	3	3	3	3	3	3	3
	113	126	143	157	212	262	287	286	323	368
	3	0	0	1	1	0	1	2	2	2
Trade Payables	25	26	30	31	41	60	47	56	69	71
	5	7	7	9	14	21	20	17	21	59
Total Liabilities	149	162	183	201	271	346	358	364	418	504
	27	28	26	26	23	28	49	50	49	51
Capital Work in Progress	1	0	0	0	0	16	1	2	16	105
	10	8	18	18	18	13	5	0	0	3
	10	10	15	24	17	26	29	29	27	37
	0	0	0	26	0	0	0	48	56	61
Cash & Bank	31	73	81	36	139	88	70	27	83	33
	71	44	44	70	73	175	203	208	186	212
Total Assets	149	162	183	201	271	346	358	364	418	504

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	22	30	31	18	110	76	36	28	51	36
Cash from Investing	-0	-8	-11	-14	-88	-36	-2	19	-31	-21
Cash from Financing	-5	-9	-7	-12	-7	-17	-15	-48	-13	-14
	3	2	3	-7	-4	-1	3	-1	6	1

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026

Shareholding Pattern

Numbers in percentages

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	50.59	46.52	46.52	46.52	46.52	46.52	46.52	46.52	46.52
	1.55	2.34	2.30	2.30	2.41	2.38	2.27	2.17	2.44
	7.32	10.60	11.13	11.41	12.70	12.90	13.00	12.66	12.29
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	40.54	40.54	40.06	39.77	38.37	38.20	38.22	38.65	38.76

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-08-28

Updates

2026-08-28 - Amrutanjan Health Care Limited has informed the Exchange regarding 'BRSR for the FY 2025-26'.

2026-08-28

Shareholders meeting

2026-08-28 - Amrutanjan Health Care Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 23, 2026

2026-08-12

Investor Presentation

2026-08-12 - Amrutanjan Health Care Limited has informed the Exchange about Investor Presentation

2026-08-11

Record Date

2026-08-11 - Amrutanjan Health Care Limited has informed the Exchange that Record date for the purpose of Dividend & Meeting is 11-Sep-2026.

2026-08-11

Outcome of Board Meeting

2026-08-11 - Amrutanjan Health Care Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

2026-08-05

Commencement of commercial production/operations

2026-08-05 - Amrutanjan Health Care Limited has informed the Exchange about Commencement of commercial production/operations

2026-08-05

Credit Rating

2026-08-05 - Amrutanjan Health Care Limited has informed the Exchange about Credit Rating

2026-08-01

Action(s) taken or orders passed

2026-08-01 - Amrutanjan Health Care Limited has informed the Exchange about Action(s) taken or orders passed

2026-07-08

Certificate under SEBI (Depositories and Participants) Regulations, 2018

2026-07-08 - Amrutanjan Health Care Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

News

Recent coverage and analyst commentary for AMRUTANJAN

Loading news…

🤖

AI Stock Analyst

Amrutanjan Health Care Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account